Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2026-01-29 @ 3:40 AM
Study NCT ID:
NCT05998759
Status:
RECRUITING
Last Update Posted:
2025-05-06
First Post:
2023-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Sponsor:
Beijing Hospital
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
BJ-2021-235
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER_GOV | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |